Last reviewed · How we verify

NCT07410364: DISTAL-SV

Safety and Efficacy of CAG and PCI Via Distal Transradial Access in Patients With Small Vessels

Not yet recruiting NA Last updated 13 February 2026
What this trial tests

NA trial testing Performing coronary angiography and percutaneous coronary intervention via the distal transradial access in patients with small vessels (DRA < 2.0 mm) using a 6-Fr Glidesheath Slender sheath. in Coronary Artery Disease in 594 participants. Not yet recruiting.

Timeline
1 February 2026
Primary endpoint
1 February 2028
1 February 2028

Quick facts

Lead sponsorCai gaojun, MD
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposeprevention
Enrollment594
Start date1 February 2026
Primary completion1 February 2028
Estimated completion1 February 2028
Sites2 locations across China

Drugs / interventions tested

Conditions studied

Sponsor

Cai gaojun, MD

Who can join

Adults 18 to 85, any sex, with Coronary Artery Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Randomized controlled trial of adaptive design for the safety and efficacy of coronary angiography and percutaneous coronary intervention via distal transradial access using a 6-French Glidesheath Slender in patients with small vessels.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Coronary Artery Disease

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07410364.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing